Research Article

Demonstration of Hepatitis C Virus RNA with In Situ Hybridization Employing a Locked Nucleic Acid Probe in Humanized Liver of Infected Chimeric Mice and in Needle-Biopsied Human Liver

Table 1

HCV-RNA demonstration with LNA-based ISH and nested RT-PCR in FFPE human liver tissues.

Patient Biopsy or
surgery
Diagnosis
New Inuyama Classification
SerumFFPE liver tissue
HCV-RNA (KIU/mL)Nested RT-PCRNested RT-PCRISH

Case  1BChronic hepatitis C, A2F25,1 × 102 1b1b+Focal/partial
Case  2BChronic hepatitis C, A1F12,8 × 1021b1b+Focal/partial
Case  3BChronic hepatitis C, A2,F12,4 × 1022a2a+Diffuse
Case  4BChronic hepatitis C, A1F01,9 × 1022a2a
Case  5BChronic hepatitis C, A1F12,5 × 1021b1b+Focal/partial
Case  6BChronic hepatitis C, A2F32,7 × 1021b
Case  7BChronic hepatitis C, A2F12,2 × 1022a+Focal/partial
Case  8BChronic hepatitis C, A3F35,1 × 1021b1b+Focal/partial
Case  9BChronic hepatitis C, A2F12,9 × 1021b1b+Diffuse
Case  10BChronic hepatitis C, A2F23,1 × 1022a+Focal/partial
Case  11BChronic hepatitis C, A2F33,3 × 1021b1b+Diffuse

Case  12BChronic hepatitis B, A3F3Not detectedNot done
Case  13BFatty liver, A0F0Not detectedNot done
Case  14BAutoimmune hepatitis, A3F3Not detectedNot done
Case  15SHepatitis-B-related HCC
Chronic hepatitis B, A2F2
Not detectedNot done
Case  16SHepatitis-C-related HCC84Not done

New Inuyama Classification (1996).
Activity of inflammation: A1: mild, A2: moderate, and A3: severe.
Fibrosis: F0: none, F1: portal widening, F2: bridging fibrosis, and F3: bridging fibrosis with lobular distortion.